When we dichotomized individuals based on their baseline PAI1 levels into low and high organizations based on a 15?ng/ml cutoff and performed a survival analysis using the KaplanCMeier method, we found individuals with low basal PAI1 levels had a significantly shorter PFS compared to individuals with high basal levels with EGFR TKI treatment (P?=?0

When we dichotomized individuals based on their baseline PAI1 levels into low and high organizations based on a 15?ng/ml cutoff and performed a survival analysis…